- Home
- SUPN vs KN Comparison
SUPN vs KN Comparison
Compare SUPN & KN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SUPN
- KN
- Stock Information
- Founded
- SUPN 2005
- KN 1946
- Country
- SUPN United States
- KN United States
- Employees
- SUPN N/A
- KN N/A
- Industry
- SUPN Biotechnology: Pharmaceutical Preparations
- KN Consumer Electronics/Appliances
- Sector
- SUPN Health Care
- KN Consumer Staples
- Exchange
- SUPN Nasdaq
- KN Nasdaq
- Market Cap
- SUPN 1.7B
- KN 1.8B
- IPO Year
- SUPN 2012
- KN N/A
- Fundamental
- Price
- SUPN $30.76
- KN $14.44
- Analyst Decision
- SUPN Hold
- KN Hold
- Analyst Count
- SUPN 2
- KN 1
- Target Price
- SUPN $36.00
- KN $19.00
- AVG Volume (30 Days)
- SUPN 647.0K
- KN 1.0M
- Earning Date
- SUPN 05-07-2025
- KN 04-24-2025
- Dividend Yield
- SUPN N/A
- KN N/A
- EPS Growth
- SUPN 6500.00
- KN N/A
- EPS
- SUPN 1.32
- KN N/A
- Revenue
- SUPN $661,817,000.00
- KN $553,500,000.00
- Revenue This Year
- SUPN N/A
- KN $4.73
- Revenue Next Year
- SUPN $9.32
- KN $6.34
- P/E Ratio
- SUPN $23.30
- KN $55.54
- Revenue Growth
- SUPN 8.94
- KN 21.17
- 52 Week Low
- SUPN $25.53
- KN $12.19
- 52 Week High
- SUPN $40.28
- KN $20.86
- Technical
- Relative Strength Index (RSI)
- SUPN 40.39
- KN 43.23
- Support Level
- SUPN $29.77
- KN $13.87
- Resistance Level
- SUPN $34.26
- KN $15.00
- Average True Range (ATR)
- SUPN 1.51
- KN 0.77
- MACD
- SUPN -0.04
- KN 0.11
- Stochastic Oscillator
- SUPN 22.05
- KN 69.66
About SUPN Supernus Pharmaceuticals Inc.
Supernus Pharmaceuticals Inc is a specialty pharmaceutical company. The company is engaged in developing and commercializing products for the treatment of central nervous system diseases, including neurological and psychiatric disorders. Its diverse neuroscience portfolio includes approved treatments for epilepsy, migraine, attention-deficit hyperactivity disorder (ADHD), hypomobility in Parkinson's Disease (PD), cervical dystonia, chronic sialorrhea, dyskinesia in PD patients receiving levodopa-based therapy, and drug-induced extrapyramidal reactions in adult patients. The company's products include Trokendi XR, Oxtellar XR, Qelbree, APOKYN, XADAGO, MYOBLOC, GOCOVRI, and Osmolex ER.
About KN Knowles Corporation
Knowles Corp is engaged in the manufacturing of micro-acoustic microphones and balanced armature speakers, audio solutions, high-performance capacitors, and radio frequency filtering products. It operates in three segments; the Precision Devices segment specializes in the design and delivery of high-performance capacitor products and RF solutions, Medtech & Specialty Audio segment designs and manufactures microphones and balanced armature speakers used in applications and the Consumer MEMS Microphones segment designs and manufactures micro-electro-mechanical systems microphones and audio solutions used in applications. The majority of its revenue comes from the Consumer MEMS Microphones segment.